Chew Hall F
Department of Ophthalmology and Vision Sciences, University of Toronto, Ontario, Canada M4N 3M5.
Saudi J Ophthalmol. 2011 Jul;25(3):213-8. doi: 10.1016/j.sjopt.2011.04.012. Epub 2011 May 24.
Anterior segment stem cell technology, due to its already well-defined corneal limbal stem cells with greater ease of evaluation, has been at the forefront of ophthalmic stem cell treatment and technology since 1997. This paper provides an overview of the current standard of care for treatment of limbal stem-cell deficient conditions and reviews recent treatment technologies using ex vivo expansion of cultivated limbal stem cells of the cornea.
前段干细胞技术,因其已明确的角膜缘干细胞更易于评估,自1997年以来一直处于眼科干细胞治疗和技术的前沿。本文概述了目前治疗角膜缘干细胞缺乏症的护理标准,并综述了最近使用体外扩增培养角膜缘干细胞的治疗技术。